Malignant comorbidity: schizophrenia and smoking
- Authors: Sivolap Y.P.1, Portnova A.A.2
-
Affiliations:
- Peoples' Friendship University of Russia
- Scientific and Practical Center of Child Psychoneurology
- Issue: Vol LVII, No 1 (2025)
- Pages: 80-88
- Section: Reviews
- URL: https://journals.rcsi.science/1027-4898/article/view/292661
- DOI: https://doi.org/10.17816/nb643639
- ID: 292661
Cite item
Abstract
The prevalence of smoking among individuals with schizophrenia is higher than in those with other mental disorders and several times greater than in the general population. Moreover, the severity of tobacco dependence in patients with schizophrenia significantly exceeds that in individuals without serious psychiatric illnesses. Schizophrenia is associated with an increased susceptibility to cardiovascular and metabolic diseases, as well as a high rate of premature mortality due to both medical causes and suicide. Smoking significantly magnifies the issue, contributing to both poor physical health and increased mortality rates. The decrease in tobacco use observed in many regions of the world over recent decades has only minimally affected individuals with schizophrenia. Standard smoking reduction strategies and tobacco dependence treatments have proven ineffective or insufficiently effective for individuals with schizophrenia, which highlights the need for the development of new preventive measures and therapeutic interventions.
Full Text
##article.viewOnOriginalSite##About the authors
Yury P. Sivolap
Peoples' Friendship University of Russia
Author for correspondence.
Email: yura-sivolap@yandex.ru
ORCID iD: 0000-0002-4494-149X
SPIN-code: 3586-5225
MD, Dr. Sci. (Medicine), Professor
Russian Federation, MoscowAnna A. Portnova
Scientific and Practical Center of Child Psychoneurology
Email: aapserbsky@mail.ru
ORCID iD: 0000-0001-5938-0202
SPIN-code: 5899-0069
MD, Dr. Sci. (Medicine), Chief Scientific Associate
Russian Federation, MoscowReferences
- Castle DJ, Buckley PF. Schizophrenia. Second Revised Edition. Oxford: Oxford University Press; 2012.
- Kurdyak P, Mallia E, de Oliveira C, et al. Mortality after the first diagnosis of schizophrenia-spectrum disorders: a population-based retrospective cohort study. Schizophr-Bull. 2021;47(3):864–874. doi: 10.1093/schbul/sbaa180
- Moreno-Küstner B, Guzman-Parra J, Pardo Y, et al. Excess mortality in patients with schizophrenia spectrum disorders in Malaga (Spain): a cohort study. Epidemiol Psychiatr Sci. 2021;30:e11. doi: 10.1017/S2045796020001146
- Ringen PA, Engh JA, Birkenaes AB, et al. Increased mortality in schizophrenia due to cardiovascular disease — a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry. 2014;5:137. doi: 10.3389/fpsyt.2014.00137
- Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014:10:425–48. doi: 10.1146/annurev-clinpsy-032813-153657
- Myles N, Newall HD, Curtis J, et al. Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatry. 2012;73(4):468–475. doi: 10.4088/JCP.11r07222
- Ding JB, Hu K. Cigarette smoking and schizophrenia: etiology, clinical, pharmacological, and treatment implications. Schizophr Res Treatment. 2021;2021:7698030. doi: 10.1155/2021/7698030
- Dickerson F, Schroeder J, Katsafanas E, et al. Cigarette smoking by patients with serious mental illness, 1999–2016: an increasing disparity. Psychiatr Serv. 2018;69(2):147–153. doi: 10.1176/appi.ps.201700118
- Freudenreich O. Psychotic disorders: a practical guide. Second Edition. Cham: Humana Press; 2020. doi: 10.1007/978-3-030-29450-2
- Hirasawa-Fujita M, Bly MJ, Ellingrod VL, et al. Genetic variation of the mu opioid receptor (OPRM1) and dopamine D2 receptor (DRD2) is related to smoking differences in patients with schizophrenia but not bipolar disorder. Clin Schizophr Relat Psychoses. 2017;11(1):39–48. doi: 10.3371/1935-1232-11.1.39
- de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76(2-3):135–157. doi: 10.1016/j.schres.2005.02.010
- Dickerson F, Stallings CR, Origoni AE, et al. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999–2011. Psychiatr Serv. 2013;64(1):44–50. doi: 10.1176/appi.ps.201200143
- Šagud M, Vuksan-Ćusa B, Jakšić M, et al. Nicotine dependence in Croatian male inpatients with schizophrenia. BMC Psychiatry. 2018;18(1):18. doi: 10.1186/s12888-018-1606-1
- Dervaux A, Laqueille X. [Smoking and schizophrenia: epidemiological and clinical features]. Encephale. 2008;34(3):299–305. doi: 10.1016/j.encep.2007.04.003
- Diaz FJ, Velásquez DM, Susce MT, de Leon J. The association between schizophrenia and smoking: unexplained by either the illness or the prodromal period. Schizophr Res. 2008;104(1-3):214–219. doi: 10.1016/j.schres.2008.06.004
- Taylor GMT, Treur JL. An application of the stress-diathesis model: A review about the association between smoking tobacco, smoking cessation, and mental health. Int J Clin Health Psychol. 2023;23(1):100335. doi: 10.1016/j.ijchp.2022.100335
- Ohi K, Kuwata A, Shimada T, et al. Genome-wide variants shared between smoking quantity and schizophrenia on 15q25 are associated with CHRNA5 expression in the brain. Schizophr Bull. 2019;45(4):813–823. doi: 10.1093/schbul/sby093
- Subramaniyan M, Dani JA. Dopaminergic and cholinergic learning mechanisms in nicotine addiction. Ann N Y Acad Sci. 2015;1349(1):46–63. doi: 10.1111/nyas.12871
- Berlin I, Anthenelli RM. Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol. 2001;4(1):33–42. doi: 10.1017/S1461145701002188
- Parikh V, Kutlu MG, Gould TJ. nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: current trends and perspectives. Schizophr Res. 2016;171(1-3):1–15. doi: 10.1016/j.schres.2016.01.020
- Gage SH, Munafò MR. Rethinking the association between smoking and schizophrenia. Lancet Psychiatry. 2015;2(2):118–119. doi: 10.1016/S2215-0366(14)00057-1
- Koster M, Mannsdörfer L, van der Pluijm M, et al. The association between chronic tobacco smoking and brain alterations in schizophrenia: a systematic review of magnetic resonance imaging studies. Schizophr Bull. 2024:sbae088. doi: 10.1093/schbul/sbae088
- Krishnadas R, Jauhar S, Telfer S, et al. Nicotine dependence and illness severity in schizophrenia. Br J Psychiatry. 2012;201(4):306–312. doi: 10.1192/bjp.bp.111.107953
- Dalack GW, Healy DJ, Meador-Woodruff JH. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry. 1998;155(11):1490–1501. doi: 10.1176/ajp.155.11.1490
- Mu X, Wu W, Wang S, et al. Smoking affects symptom improvement in schizophrenia: a prospective longitudinal study of male patients with first-episode schizophrenia. Schizophrenia (Heidelb). 2024;10(1):34. doi: 10.1038/s41537-024-00449-1
- Coustals N, Martelli C, Brunet-Lecomte M, et al. Chronic smoking and cognition in patients with schizophrenia: A meta-analysis. Schizophrenia Research. 2020;222:113–121. doi: 10.1016/j.schres.2020.03.071
- Kanniah G, Kumar R. A selective literature review exploring the role of the nicotinic system in schizophrenia. Gen Psychiatr. 2023;36(2):e100756. doi: 10.1136/gpsych-2022-100756
- Hjorthøj C, Stürup AE, McGrath JJ, Nordentoft M. Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis. Lancet Psychiatry. 2017;4(4):295–301. doi: 10.1016/S2215-0366(17)30078-0
- Kelly DL, McMahon RP, Wehring HJ, et al. Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull. 2011;37(4):832–838. doi: 10.1093/schbul/sbp152
- Zeng L-N, Zong Q-Q, Zhang L, et al. Worldwide prevalence of smoking cessation in schizophrenia patients: A meta-analysis of comparative and observational studies. Asian J Psychiatr. 2020;54:102190. doi: 10.1016/j.ajp.2020.102190
- Hartz SM, Pato CN, Medeiros H, et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry. 2014;71(3):248–254. doi: 10.1001/jamapsychiatry.2013.3726
- Johnstone S, Hubbard AN, Schenkel A, et al. Effects of acute smoking abstinence among people with schizophrenia: A systematic review and meta-analysis of laboratory studies. Schizophr Res. 2024;274:220–236. doi: 10.1016/j.schres.2024.09.025
- Brady DJ, Phalen PL, Roche DJO, et al. A reduction in cigarette smoking improves health-related quality of life and does not worsen psychiatric symptoms in individuals with serious mental illness. Addict Behav. 2024;151:107949. doi: 10.1016/j.addbeh.2023.107949
Supplementary files
